Elanco stock: 2026 outlook raised after third-quarter growth

Published on 11/06/2026 at 22:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elanco raised its 2026 outlook after reporting strong third-quarter growth. Elanco stock is in focus as investors assess the improved earnings trajectory.

Elanco raises its full-year outlook

Third-quarter revenue increased 11 percent year over year to USD 1.265 billion.
Adjusted earnings per share rose to USD 0.27, while adjusted EBITDA increased 23 percent to USD 243 million.
Elanco lifted its 2026 revenue and adjusted earnings guidance after the quarter.

ELAN, US28414H1032, Illustration mit AI erstellt.

Elanco Animal Health reported stronger third-quarter operating results and raised its full-year 2026 outlook on Friday, November 6. The company said revenue rose 11 percent year over year to USD 1.265 billion for the quarter ended September 30, according to its PR Newswire release.

Revenue growth broadens across operations

Pet Health revenue increased 14 percent to USD 608 million, supported by demand for Zenrelia, Credelio Quattro and AdTab. Farm Animal revenue rose 6 percent to USD 631 million, with cattle revenue up 17 percent and poultry revenue down 7 percent.

Reported net income was USD 18 million, compared with a USD 34 million loss in the year-earlier quarter. Adjusted net income rose 45 percent to USD 136 million, or USD 0.27 per diluted share. The adjusted figures exclude items including intangible-asset amortization, restructuring charges and other specified adjustments.

Adjusted EBITDA increased 23 percent to USD 243 million. Adjusted EBITDA margin reached 19.5 percent, compared with 17.5 percent a year earlier, while adjusted gross margin expanded to 56.1 percent from 53.1 percent.

Higher guidance sets next benchmark

Elanco raised its 2026 revenue guidance to USD 5.155 billion to USD 5.18 billion from USD 5.09 billion to USD 5.14 billion previously. Adjusted EBITDA guidance now stands at USD 1.05 billion to USD 1.065 billion, and adjusted earnings per share guidance increased to USD 1.17 to USD 1.20 from USD 1.10 to USD 1.16.

The company also expects fourth-quarter revenue of USD 1.19 billion to USD 1.215 billion and adjusted earnings per share of USD 0.16 to USD 0.19. Management said the quarter's performance reflected stronger pricing, favorable product mix and progress on productivity initiatives.

Elanco stock traded at 22.93 euros on Lang & Schwarz at 10:19 p.m. CET on Friday, November 6, 2026. Investors can follow the real-time quote of Elanco stock for the latest price.